The CDC is working with the FDA to investigate at least 19 reports of harmful reactions linked to counterfeit or mishandled Botox injections in nine states. Nine of the patients were hospitalized, the agency said.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
